Phase I clinical study of KD 025 in healthy volunteers

Trial Profile

Phase I clinical study of KD 025 in healthy volunteers

Phase of Trial: Phase I

Latest Information Update: 19 Nov 2013

At a glance

  • Drugs KD 025 (Primary)
  • Indications Autoimmune disorders; Cancer; Non-alcoholic steatohepatitis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 19 Nov 2013 Status changed from recruiting to completed, based on information in an article published in Annals of Clinical and Translational Neurology.
    • 27 Feb 2012 Dosing of subjects has been initiated, according to a Kadmon Corporation media release
    • 27 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top